Cytokinetics Inc (CYTK) stock
CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.32−0.33 (-0.64%)
Close on Nov 18, 2026Market cap $7.13BP/E –Yield –
Cytokinetics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cytokinetics's pe ratio was 702.5× on Jul 31, 2017, against 6.5× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2017 | Jul 31, 2017 | 702.5× | +698.0 |
| 2011 | Jan 31, 2011 | 4.5× | −0.5 |
| 2010 | Dec 31, 2010 | 5.0× | – |
See a number that looks wrong?